Pharmacy

A U.S. Bankruptcy Court Judge approved the sale of Shopko's prescription files and related pharmacy assets to more than 20 drugstore and grocery chains Jan. 18, according to Forbes.

Eighteen of the current top 20 brand-name medications will face competition from generics or other biosimilars by 2023, according to a new report from IQVIA Institute for Human Data Science.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership talent in the last two weeks.

AstraZeneca has agreed to a pay-for-performance deal with UPMC Health Plan, according to STAT.

Pfizer launched China's first pay-for-performance model for oncology, according to a BioCentury news report.  The model was launched for Pfizer's breast cancer drug, Ibrance.

Last September, CMS threatened to terminate Dillingham, Alaska-based Kanakanak Hospital's Medicare contract for pharmacy deficiencies. After a plan of correction, the hospital has retained funding, according to Alaska Public Radio.

As many as 2 million patients worldwide likely have been exposed to a class of generic blood-pressure drugs containing probable human carcinogens, the FDA estimates in a report from The Wall Street Journal.

The Pharmaceutical Research and Manufacturers of America, the industry's main trade group, is considering a proposal that will cap drug price increases for Medicare, according to a report from BioCentury.

CVS Health, which operates one of the largest pharmacy benefit manager units in the U.S., has added migraine drugs from Teva Pharmaceuticals and Eli Lilly to its formulary, while excluding coverage of a rival treatment from Amgen, Reuters reports.

Walgreens will acquire about half of Shopko's pharmacies, according to The Wall Street Journal.